Bispecific antibodies which comprise one antigen binding region binding to an epitope of human epidermal growth factor receptor 2 (HER2) and one antigen binding region binding to human CD3 and related antibody based compositions and molecules are disclosed. Pharmaceutical compositions comprising the antibodies and methods for preparing and using the antibodies are also disclosed.